AU2001242795A1 - Condensed pyrazole derivatives, process for producing the same and use thereof - Google Patents

Condensed pyrazole derivatives, process for producing the same and use thereof

Info

Publication number
AU2001242795A1
AU2001242795A1 AU2001242795A AU4279501A AU2001242795A1 AU 2001242795 A1 AU2001242795 A1 AU 2001242795A1 AU 2001242795 A AU2001242795 A AU 2001242795A AU 4279501 A AU4279501 A AU 4279501A AU 2001242795 A1 AU2001242795 A1 AU 2001242795A1
Authority
AU
Australia
Prior art keywords
producing
same
pyrazole derivatives
condensed pyrazole
condensed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001242795A
Inventor
Akiko Asakawa
Hiroyuki Kimura
Keita Mitsui
Masahiro Mizuno
Shigeru Morimoto
Takeo Moriya
Osamu Uchikawa
Masataka Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2001242795A1 publication Critical patent/AU2001242795A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001242795A 2000-03-27 2001-03-27 Condensed pyrazole derivatives, process for producing the same and use thereof Abandoned AU2001242795A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000-086313 2000-03-27
JP2000086313 2000-03-27
JP2000-086524 2000-03-27
JP2000086524 2000-03-27
PCT/JP2001/002439 WO2001072749A1 (en) 2000-03-27 2001-03-27 Condensed pyrazole derivatives, process for producing the same and use thereof

Publications (1)

Publication Number Publication Date
AU2001242795A1 true AU2001242795A1 (en) 2001-10-08

Family

ID=26588408

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001242795A Abandoned AU2001242795A1 (en) 2000-03-27 2001-03-27 Condensed pyrazole derivatives, process for producing the same and use thereof

Country Status (5)

Country Link
US (1) US6949648B2 (en)
EP (1) EP1270572A4 (en)
AU (1) AU2001242795A1 (en)
CA (1) CA2404669A1 (en)
WO (1) WO2001072749A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1380296A1 (en) * 2001-03-28 2004-01-14 Takeda Chemical Industries, Ltd. Hsp inductor
EP1648455A4 (en) * 2003-07-23 2009-03-04 Exelixis Inc Anaplastic lymphoma kinase modulators and methods of use
AU2004293019B2 (en) * 2003-11-19 2010-10-28 Array Biopharma Inc. Bicyclic inhibitors of MEK and methods of use thereof
CA2555287A1 (en) * 2004-02-18 2005-08-25 David Garrett Loughhead Heterocyclic gaba-a subtype selective receptor modulators
EP1928455A1 (en) * 2005-08-31 2008-06-11 Bayer Healthcare, LLC Anilinopyrazole derivatives useful for the treatment of diabetes
EP2578561A1 (en) * 2005-09-29 2013-04-10 Albany Molecular Research, Inc. Processes for the production of cannabidiol derivatives and intermediates thereof
ES2473344T3 (en) * 2006-02-15 2014-07-04 Abbvie Inc. Pyrazoloquinolones are potent inhibitors of PARP
AU2009335016A1 (en) * 2008-12-30 2011-08-18 Arqule, Inc. Substituted pyrazolo [3, 4-b] pyridine compounds
US10272074B2 (en) * 2015-01-29 2019-04-30 Sanford Burnham Prebys Medical Discovery Institute Inhibitors of glucocorticoid receptor translocation
WO2022117882A2 (en) * 2020-12-03 2022-06-09 Domain Therapeutics Novel par-2 inhibitors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855675A (en) * 1971-05-25 1974-12-24 Squibb & Sons Inc 1-(2-furanylmethyl)-1h-pyrazolo(3,4-b)pyridine-5-methanones
US3773778A (en) * 1972-01-24 1973-11-20 Squibb & Sons Inc Sulfur derivatives of pyrazolo (3,4-b)pyridines
US3903096A (en) 1974-03-29 1975-09-02 Squibb & Sons Inc New derivatives of sulfonyl-, sulfinyl- and sulfenyl-1H-pyrazolo {8 3,4-b{9 -pyridines
US3935222A (en) * 1975-04-16 1976-01-27 E. R. Squibb & Sons, Inc. 1,4,5,7-Tetrahydropyrazolo[3,4-b]pyridin-6-ones
US4111940A (en) 1977-04-07 1978-09-05 E. R. Squibb & Sons, Inc. 1,5,6,11-Tetrahydro[5,6]cyclohepta-[1,2,-b]pyrazolo[4,3-e]pyridine derivatives
US4179564A (en) 1977-04-07 1979-12-18 E. R. Squibb & Sons, Inc. 1,5,6,11-Tetrahydro[5,6]cyclohepta[1,2-b]pyrazolo[4,3-e]pyridine derivatives
JPH0717641B2 (en) 1986-03-31 1995-03-01 日産化学工業株式会社 Imidazoline derivative, its manufacturing method and herbicide
JPH0615542B2 (en) * 1986-07-22 1994-03-02 吉富製薬株式会社 Pyrazolopyridine compound
US4920128A (en) 1987-07-08 1990-04-24 Sterling Drug Inc. Pyrazolo[3,4-b]quinolines and their use as antiviral agents
JP2701281B2 (en) 1988-01-22 1998-01-21 吉富製薬株式会社 Pyrazolopyridine compound
US5024999A (en) * 1988-04-26 1991-06-18 Nissan Chemical Industries Ltd. Pyrazolopyridine type mevalonolactones useful as pharmaeuticals
JP2890448B2 (en) 1988-04-26 1999-05-17 日産化学工業株式会社 Pyrazolopyridine mevalonolactones
JPH03271289A (en) 1990-03-16 1991-12-03 Nissan Chem Ind Ltd Production of pyrazolopyridine derivative and dihydropyrazolopyridine derivative
JPH072786A (en) 1993-03-15 1995-01-06 Yoshitomi Pharmaceut Ind Ltd Pyrazole compound
US5506236A (en) 1994-04-28 1996-04-09 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US5597821A (en) 1994-12-15 1997-01-28 Wolin; Ronald L. Pyrazoloquinolines
US5595998A (en) * 1994-12-15 1997-01-21 Wolin; Ronald L. Pyrazoloquinolines

Also Published As

Publication number Publication date
US20030187014A1 (en) 2003-10-02
CA2404669A1 (en) 2001-10-04
US6949648B2 (en) 2005-09-27
EP1270572A1 (en) 2003-01-02
EP1270572A4 (en) 2005-03-23
WO2001072749A1 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
IL146105A0 (en) 5-pyridyl-1, 3-azole compounds, process for producing the same and use thereof
AU2002349477A1 (en) Bicyclic derivative, process for producing the same, and use
MXPA02008801A (en) Indole derivatives, process for preparation of the same and use thereof.
AU2001294228A1 (en) Benzimidazole compounds, process for producing the same and use thereof
AU2002318742A1 (en) Pullulan-containing powder, process for producing the same and use thereof
AU2001242795A1 (en) Condensed pyrazole derivatives, process for producing the same and use thereof
AU2001289695A1 (en) Impregnate, method for the production and use thereof
AU2000254308A1 (en) Pyrazolopyrimidinone derivatives, process for their preparation and their use
AU2003289176A1 (en) 1,3-benzothiazinone derivatives, process for producing the same and use thereof
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
AU2002218400A1 (en) 3-substituted 2,7-naphthyridin-1-yl derivatives
AU2796602A (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
AU2001286188A1 (en) Tricyclic heterocyclic compound, process for producing the same, and use thereof
AU2001242750A1 (en) Novel protein, process for producing the same and use thereof
AU2001252254A1 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparationthereof and use thereof
AU2002229149A1 (en) Process for producing hydrazinomonosaccharide derivatives and use thereof
AU2002348998A1 (en) N-methyl-homocystines, use thereof and method for the production thereof
AU2002233219A1 (en) Aqueous, effect-bearing coating substance, method for producing the same and use thereof
AU2002227952A1 (en) Klainetin and derivatives thereof, method for their production and the use of the same
MXPA03004632A (en) Klainetin and derivatives thereof, method for their production and the use of the same.
AU6730001A (en) Component, method for production and use thereof
AU2001294181A1 (en) Novel protein, process for producing the same and use thereof
AU2001232226A1 (en) 1,3,4-oxadiazole derivatives and process for producing the same
HK1052709A1 (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof pluraflavin.